For decades, scientists, researchers, hospitals and clinics have been amassing a stockpile of information on cancer. This data takes many forms: medical texts and journals, patient records, medical images, genetic profiles and more. And it lives in many places — from highly structured digital databases to forgotten filing cabinets, owned by government agencies, insurance companies, research scientists and healthcare providers. In a sense, we’ve become data rich. But somehow, we remain insight poor.